How many insider trades does FilingIQ track for ACET?

FilingIQ tracks 429 Form 4 insider transactions for ACET (Adicet Bio, Inc.), covering filings from May 21, 2015 onwards. 14 of those were filed in the last 90 days.

Are ACET insiders net buyers or net sellers?

Across the full Form 4 history for ACET, 24 transactions (6%) were open-market purchases and 180 (42%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ACET insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ACET in?

Adicet Bio, Inc. (ACET) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $65.38M.

ACET insider trading

NasdaqCM Healthcare

Adicet Bio, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

429

Last 90 days

Buys / sells

6% / 42%

Market cap

$65.38M

About Adicet Bio, Inc.

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.

Company website: www.adicetbio.com

ACET insider activity at a glance

FilingIQ has scored 429 insider transactions for ACET since May 21, 2015. The most recent filing in our index is dated Apr 27, 2026.

Across the full history, 24 open-market purchases and 180 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ACET insider trades is 59.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ACET trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ACET?: FilingIQ tracks 429 Form 4 insider transactions for ACET (Adicet Bio, Inc.), covering filings from May 21, 2015 onwards. 14 of those were filed in the last 90 days.
Are ACET insiders net buyers or net sellers?: Across the full Form 4 history for ACET, 24 transactions (6%) were open-market purchases and 180 (42%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ACET insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ACET in?: Adicet Bio, Inc. (ACET) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $65.38M.

Methodology & sources

Every ACET insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.